Your browser doesn't support javascript.
loading
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
Kasper, Bernd; D'Ambrosio, Lorenzo; Davis, Elizabeth J; Ingham, Matthew; Broto, Javier Martin; Trent, Jonathan C; van Houdt, Winan J; Van Tine, Brian A.
Afiliación
  • Kasper B; Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68167, Mannheim, Germany. bernd.kasper@umm.de.
  • D'Ambrosio L; Department of Oncology, University of Turin, Turin, Italy.
  • Davis EJ; Department of Internal Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA.
  • Ingham M; Columbia University School of Medicine, New York, USA.
  • Broto JM; Medical Oncology Department, University Hospital Fundacion Jimenez Diaz, Madrid, Spain.
  • Trent JC; Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
  • van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Van Tine BA; Siteman Cancer Center, Washington University in St. Louis, St. Louis, USA.
Curr Treat Options Oncol ; 23(3): 439-449, 2022 03.
Article en En | MEDLINE | ID: mdl-35275323

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Leiomiosarcoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Leiomiosarcoma Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Curr Treat Options Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania